Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

LETTER

Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant

I Del Corso, I Puxeddu, E Sardano, S Geraci, M Breggia, V Rocchi, P Migliorini

Annals of Allergy, Asthma & Immunology 2012, 108 (6): 460-1

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema. Jens Greve, Thomas K Hoffmann, Patrick Schuler, Stephan Lang, Adam Chaker, Murat Bas International Journal of Dermatology 2011, 50 (10): 1294-5

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant. M Bas, H Bier, J Greve, G Kojda, T K Hoffmann Allergy 2006, 61 (12): 1490-2

Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems. Delphine Charignon, Peter Späth, Ludovic Martin, Christian Drouet Expert Opinion on Pharmacotherapy 2012, 13 (15): 2233-47

Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Murat Bas, Jens Greve, Klaus Stelter, Henning Bier, Thomas Stark, Thomas K Hoffmann, Georg Kojda Annals of Emergency Medicine 2010, 56 (3): 278-82

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). Konrad Bork, Jorge Frank, Boris Grundt, Peter Schlattmann, Juerg Nussberger, Wolfhart Kreuz Journal of Allergy and Clinical Immunology 2007, 119 (6): 1497-503

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. Marco Cicardi, Aleena Banerji, Francisco Bracho, Alejandro Malbrán, Bernd Rosenkranz, Marc Riedl, Konrad Bork, William Lumry, Werner Aberer, Henning Bier, Murat Bas, Jens Greve, Thomas K Hoffmann, Henriette Farkas, Avner Reshef, Bruce Ritchie, William Yang, Jürgen Grabbe, Shmuel Kivity, Wolfhart Kreuz, Robyn J Levy, Thomas Luger, Krystyna Obtulowicz, Peter Schmid-Grendelmeier, Christian Bull, Brigita Sitkauskiene, William B Smith, Elias Toubi, Sonja Werner, Suresh Anné, Janne Björkander, Laurence Bouillet, Enrico Cillari, David Hurewitz, Kraig W Jacobson, Constance H Katelaris, Marcus Maurer, Hans Merk, Jonathan A Bernstein, Conleth Feighery, Bernard Floccard, Gerald Gleich, Jacques Hébert, Martin Kaatz, Paul Keith, Charles H Kirkpatrick, David Langton, Ludovic Martin, Christiane Pichler, David Resnick, Duane Wombolt, Diego S Fernández Romero, Andrea Zanichelli, Francesco Arcoleo, Jochen Knolle, Irina Kravec, Liying Dong, Jens Zimmermann, Kimberly Rosen, Wing-Tze Fan New England Journal of Medicine 2010 August 5, 363 (6): 532-41

Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. William R Lumry, H Henry Li, Robyn J Levy, Paul C Potter, Henriette Farkas, Dumitru Moldovan, Marc Riedl, Hongbin Li, Timothy Craig, Bradley J Bloom, Avner Reshef Annals of Allergy, Asthma & Immunology 2011, 107 (6): 529-37

Nonhistaminergic idiopathic angioedema: clinical response to icatibant. C Colás, R Montoiro, J Fraj, M Garcés, J L Cubero, T Caballero Journal of Investigational Allergology & Clinical Immunology 2012, 22 (7): 520-1

Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant. Peter W Schmidt, Michael M Hirschl, Franz Trautinger Journal of the American Academy of Dermatology 2010, 63 (5): 913-4

Icatibant for hereditary angioedema. Jordi Gras Drugs of Today 2009, 45 (12): 855-64

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips